NovoCure
NVCR
NVCR
197 hedge funds and large institutions have $4.17B invested in NovoCure in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 57 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2.01% more ownership
Funds ownership: 66.92% → 68.93% (+2%)
6% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 31
2% less funds holding
Funds holding: 200 → 197 (-3)
Holders
197
Holding in Top 10
5
Calls
$88.2M
Puts
$28.7M
Top Buyers
| 1 | +$49.9M | |
| 2 | +$47.4M | |
| 3 | +$29.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$14.1M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$14.7M | |
| 3 | -$9.79M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.5M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$8.49M |